Table 13 An assessment of the changes in plasma coagulation values affected by the 90-day oral administration of 7%-GNANA, a test substance to the male and female rats (n=10)
Tests | Groups (mg/kg/day)a) |
G1% | | G2 | | G3 | | G4 |
Male | Female | | Male | Female | | Male | Female | | Male | Female |
PT (sec) | 8.54±0.370 | 8.67±0.509 | 8.66±0.354 | 8.94±0.448 | 8.33±0.341 | 8.88±0.281 | 8.49±0.293 | 8.78±0.369 |
APTT(sec) | 17.6±1.52 | 17.0±1.50 | 16.7±1.53 | 17.0±1.34 | 17.4±1.89 | 16.6±1.19 | 18.0±1.89 | 16.6±2.14 |
No. of animals | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
%: Control group (G1), Low-dose group (G2: 1,250 mg/10 mL/day), Medium-dose group (G3: 2,500 mg/10 mL/day)